Zobrazeno 1 - 10
of 35
pro vyhledávání: ''
Autor:
Andrey Sivkov, Svetlana Sivkova, Roman V. Gorenkov, Sergey Sivkov, Natalya P. Chernus, Tamara Savina
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-9 (2021)
Lipids in Health and Disease
Lipids in Health and Disease
Background To determine the effect of genetic polymorphism of drug transporters on the efficacy of treatment with Rosuvastatin, Atorvastatin and Simvastatin in patients with hyperlipidemia. Methods The study consists of 180 patients, aged 40–75 yea
Autor:
Jiacheng Lai, Qingtong Wang, Meili Dong, Bin Li, Jingshu Ni, Yikun Wang, Chongjian Huang, Yongsheng Han
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-9 (2021)
Lipids in Health and Disease
Lipids in Health and Disease
Background Lipid management is the first line of treatment for decreasing the incidence of cardiovascular events in patients with coronary heart disease (CHD), and a variety of indicators are used to evaluate lipid management. This work analyses the
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-11 (2021)
Lipids in Health and Disease
Lipids in Health and Disease
Background Dyslipidemia is a predisposing factor for coronary heart disease (CHD). High-intensity statin therapy is recommended as secondary prevention. ABCB1 and SLCO1B1 genes influence the efficacy and safety of statins. Xinjiang is a multi-ethnic
Autor:
Cheng Zhang, Liu Lu, Yukai Xiang, Yulong Yang, Xiangyu Kong, Ruiqi Lu, Chuanqi He, Jingli Cai, Bosen Zhang
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-10 (2021)
Lipids in Health and Disease
Lipids in Health and Disease
Background Pancreaticobiliary reflux (PBR) causes chronic inflammation of the gallbladder mucosa and changes in the bile components, which are known to promote gallstone formation. This study aimed to investigate the bile biochemistry changes in gall
Autor:
Marcelo Amar, Michael Stagliano, Emma Staller, Nehal N. Mehta, Kianoush Jeiran, Alan T. Remaley, Martin P. Playford, Tomas Vaisar, Scott M. Gordon
Publikováno v:
Lipids in Health and Disease, Vol 19, Iss 1, Pp 1-10 (2020)
Lipids in Health and Disease
Lipids in Health and Disease
Background Niacin has modest but overall favorable effects on plasma lipids by increasing high density lipoprotein cholesterol (HDL-C) and lowering triglycerides. Clinical trials, however, evaluating niacin therapy for prevention of cardiovascular ou
Autor:
Qi Li, Guo-En Yao, Xing-Chen Wang, Qing-Jun Liu, Peng Xie, Yi-Qing Shen, Haiyang Wang, Wen-Song Yang, Rui Li
Publikováno v:
Lipids in Health and Disease, Vol 19, Iss 1, Pp 1-9 (2020)
Lipids in Health and Disease
Lipids in Health and Disease
Background: This study aims to investigate the association of lipid ratios with intracranial atherosclerotic stenosis (ICAS) in a Chinese population.Methods: This cross-sectional study included 658 consecutive patients with ischemic stroke. Intracran
Autor:
Suresh Kumar, Priya Kashyap, Rashmi Tripathi, Noopur Jaipal, Abeer Hashem, Baby Tabassum, Heera Ram, Jaykaran Charan, Chandra Nayaka Siddaiah, Bhim Singh, Elsayed Fathi Abd_Allah
Publikováno v:
Lipids in Health and Disease, Vol 19, Iss 1, Pp 1-11 (2020)
Lipids in Health and Disease
Lipids in Health and Disease
BackgroundThe HMG-CoA reductase is key enzyme of cholesterol biosynthesis which potentially contributes in management of hypercholesterolemia. The present study was designed to assess the inhibitory effect of phytoconstituents of an ethanolic extract
Autor:
Shuo Pan, Xiao-Ming Gao, Fen Liu, Min Tao Gai, Ying Huang, X.M. Li, Yi Tong Ma, Bang Dang Chen, Yi Ning Yang, Xiang Ma, Xiao Cui Chen
Publikováno v:
Lipids in Health and Disease, Vol 18, Iss 1, Pp 1-8 (2019)
Lipids in Health and Disease
Lipids in Health and Disease
Background The study was designed to investigate lipid profile and SYNTAX score in patients with non-ST segment elevation myocardial infarction (NSTEMI). Methods 311 patients with NSTEMI were enrolled. The demographic, clinical data, blood samples an
Publikováno v:
Lipids in Health and Disease, Vol 18, Iss 1, Pp 1-7 (2019)
Lipids in Health and Disease
Lipids in Health and Disease
Background Hepatitis B virus (HBV) infection remains a global health issue associated with substantial morbidity and mortality. Serum apolipoprotein C3 (ApoC3) and apolipoprotein A5 (ApoA5) levels were decreased in chronic hepatitis B (CHB) patients,
Publikováno v:
Lipids in Health and Disease, Vol 18, Iss 1, Pp 1-9 (2019)
Lipids in Health and Disease
Lipids in Health and Disease
Background Non-alcoholic fatty liver disease (NAFLD) is closely linked to obesity, type 2 diabetes and other metabolic disorders worldwide. Crocin is a carotenoid compound possessing various pharmacological activities. In the present study, we aimed